Research programme: autologous fibroblast cell therapy - Fibrocell Science
Latest Information Update: 24 Nov 2014
At a glance
- Originator Fibrocell Science
- Developer Fibrocell Science; Uniformed Services University of the Health Sciences
- Class Cell therapies
- Mechanism of Action Cell replacements
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Skin disorders